Maintaining and reprogramming genomic androgen receptor activity in prostate cancer (vol 14, pg 178, 2014)

被引：0

作者：

Mills, Ian G.

机构：

来源：

NATURE REVIEWS CANCER | 2014年 / 14卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 50 条

[41] a novel approach for cancer therapy (vol 22, pg 14, 2014) [J].

Liu, Tianyu ;

Li, Qingyong .

JOURNAL OF DRUG TARGETING, 2014, 22 (03) :267-267

[42] ANDROGEN RECEPTOR-BINDING ACTIVITY IN HUMAN-PROSTATE CANCER [J].

BENSON, RC ;

UTZ, DC ;

HOLICKY, E ;

VENEZIALE, CM .

CANCER, 1985, 55 (02) :382-388

[43] Phase I/II trial of HIFU for prostate cancer (vol 178, pg 2366, 2007) [J].

不详 .

JOURNAL OF UROLOGY, 2008, 179 (01) :386-386

[44] The CAG repeat within the androgen receptor gene and its relationship to prostate cancer (vol 94, pg 3320, 1997) [J].

Giovannucci, E ;

Stampfer, MJ ;

Krithivas, K ;

Brown, M ;

Dahl, D ;

Brufsky, A ;

Talcott, J ;

Hennekens, CH ;

Kantoff, PW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8272-8272

[45] Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC [J].

Sena, Laura A. ;

Kumar, Rajendra ;

Sanin, David E. ;

Thompson, Elizabeth A. ;

Rosen, D. Marc ;

Dalrymple, Susan L. ;

Antony, Lizamma ;

Yang, Yuhan ;

Gomes-Alexandre, Carolina ;

Hicks, Jessica L. ;

Jones, Tracy ;

Bowers, Kiara A. ;

Eskra, Jillian N. ;

Meyers, Jennifer ;

Gupta, Anuj ;

Skaist, Alyza ;

Yegnasubramanian, Srinivasan ;

Luo, Jun ;

Brennen, W. Nathaniel ;

Kachhap, Sushant K. ;

Antonarakis, Emmanuel S. ;

De Marzo, Angelo M. ;

Isaacs, John T. ;

Markowski, Mark C. ;

Denmeade, Samuel R. .

JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23)

[46] Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome (vol 6, pg 16135, 2015) [J].

Leach, Damien A. ;

Need, Eleanor F. ;

Toivanen, Roxanne ;

Trotta, Andrew P. ;

Palethorpe, Helen M. ;

Tamblyn, David J. ;

Kopsaftis, Tina ;

England, Georgina M. ;

Smith, Eric ;

Drew, Paul A. ;

Pinnock, Carole B. ;

Lee, Peng ;

Holst, Jeff ;

Risbridger, Gail P. ;

Chopra, Samarth ;

DeFranco, Donald B. ;

Taylor, Renea A. ;

Buchanan, Grant .

ONCOTARGET, 2015, 6 (34) :36923-36923

[47] Prostate cancer: A model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model [J].

Bonaccorsi, Lorella ;

Nosi, Daniele ;

Quercioli, Franco ;

Formigli, Lucia ;

Zecchi, Sandra ;

Maggi, Mario ;

Forti, Gianni ;

Baldi, Elisabetta .

STEROIDS, 2008, 73 (9-10) :1030-1037

[48] The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells [J].

Siddiqui, Salma ;

Libertini, Stephen J. ;

Lucas, Christopher A. ;

Lombard, Alan P. ;

Baek, Han Bit ;

Nakagawa, Rachel M. ;

Nishida, Kristine S. ;

Steele, Thomas M. ;

Melgoza, Frank U. ;

Borowsky, Alexander D. ;

Durbin-Johnson, Blythe P. ;

Qi, LiHong ;

Ghosh, Paramita M. ;

Mudryj, Maria .

CANCER LETTERS, 2020, 483 :12-21

[49] Death receptor 5 expression is inversely correlated with prostate cancer progression (vol 10, pg 2279, 2014) [J].

Hernandez-Cueto, Angeles ;

Hernandez-Cueto, Daniel ;

Antonio-Andres, Gabriela ;

Mendoza-Marin, Marisela ;

Jimenez-Gutierrez, Carlos ;

Sandoval-Mejia, Ana Lilia ;

Mora-Campos, Rosario ;

Gonzalez-Bonilla, Cesar ;

Vega, Mario I. ;

Bonavida, Benjamin ;

Huerta-Yepez, Sara .

MOLECULAR MEDICINE REPORTS, 2017, 16 (04) :5738-5738

[50] Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor (vol 6, pg 703, 2000) [J].

Zhao, XY ;

Malloy, PJ ;

Krishnan, AV ;

Swami, S ;

Navone, NM ;

Peehl, DM ;

Feldman, D .

NATURE MEDICINE, 2000, 6 (08) :939-939

← 1 2 3 4 5 →